A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: a report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1. (Q73613500)
Jump to navigation
Jump to search
scientific article published on 01 July 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: a report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1. |
scientific article published on 01 July 1997 |
Statements
A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: a report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1. (English)
C A Sawka
K I Pritchard
W Shelley
G DeBoer
A H Paterson
J W Meakin
D J Sutherland